FL-JABIL
14.1.2021 14:47:33 CET | Business Wire | Press release
Jabil Inc. (NYSE: JBL) today announced the acquisition of Ecologic Brands, Inc., a leading provider of sustainable packaging specializing in paper bottle and paper-based packaging solutions. Ecologic’s Manteca, California-based operation will join the Jabil Packaging Solutions division, significantly enhancing Jabil’s sustainable packaging platform and offerings for consumer packaged goods (CPG) customers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210114005367/en/
“By fueling Ecologic’s unique paper bottle technology with Jabil’s advanced manufacturing solutions and global scale, we aim to help all consumer brands dramatically reduce plastics in packaging worldwide,” said Jason Paladino, senior vice president of Jabil and CEO of Jabil Packaging Solutions. “We’re thrilled to be adding a talented team plus unique and innovative products that directly support our customer demands and Jabil’s enterprise sustainability goals.”
In Ecologic, Jabil Packaging Solutions gains a commercially mature paper bottle solution enabled by deep material expertise and innovative manufacturing processes. Major CPG brands including L’Oréal and Seventh Generation rely on Ecologic’s eco.bottle® to significantly reduce plastic packaging and advance their sustainability goals.
“Ecologic and L’Oreal broke new ground when we incubated the world’s first shower-safe paper bottle for the Seed Phytonutrients project. We’re taking things a step further by bringing this innovative packaging solution to our market-leading Matrix and Redken Brands,” said Shane Wolf, president worldwide, American Professional Brands, L’Oréal Professional Products Division. “Jabil is synonymous with innovation, engineering, automation and scale, so we can only imagine the solutions that will emerge through its union with Ecologic Brands. The possibilities and accessibility for sustainable packaging options are now limitless.”
“Ecologic has been a great partner over the past decade in helping us reimagine the laundry bottle and we’re thrilled to see the acquisition by Jabil,” said Joey Bergstein, CEO of Seventh Generation. “The world needs solutions at scale that reduce plastic waste and improve circularity. Jabil's global scale and deep engineering expertise will propel Ecologic's sustainable packaging solutions to a global footprint, in every category and format type. It’s truly a win for customers, the planet and the industry.”
“I am so proud that our paper bottle was the world’s first breakthrough technology that helps solve the growing environmental challenges caused by plastic,” said Julie Corbett, founder and CEO of Ecologic Brands. “Our pioneering efforts created and validated market opportunity, and now, Jabil provides the ideal mix of global footprint, manufacturing excellence and a customer-first culture to fully pursue our vision of leadership.”
While the team and operations will join Jabil, the company will continue to utilize the Ecologic name as its sustainable packaging product platform. For more information about Ecologic, visit ecologicbrands.com .
About Jabil :
Jabil (NYSE: JBL) is a manufacturing solutions provider with over 260,000 employees across 100 locations in 30 countries. The world's leading brands rely on Jabil's unmatched breadth and depth of end-market experience, technical and design capabilities, manufacturing know-how, supply chain insights and global product management expertise. Driven by a common purpose, Jabil and its people are committed to making a positive impact on their local community and the environment. Visit www.jabil.com to learn more.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210114005367/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 07:00:00 CEST | Press release
Galderma received a Complete Response Letter from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization Relfydess is approved in 33 markets and already launched in more than 20, including across Europe, the Middle East and Australia, with an encouraging early launch trajectory supported by positive healthcare professional feedback Regulatory filings in other territories are ongoing and remain on track Ad hoc announcement pursuant to Art. 53 LR Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufa
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 03:45:00 CEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom